Steroid hormones and Women's health in the postmenopausal age
Description of the granted funding
The population in the Western world is aging. In Finland, there are over 1,2 million women in the postmenopausal age, about 25% of them are using postmenopausal hormone therapy (HT). The risk-benefit profile of HT is under continuous debate. The focus of this research program is in aging women's health, particularly with regard to cardiovascular disease and breast cancer, because these are the most common health problems in the postmenopausal age. Our interest is specifically in adipose tissue steroid hormone metabolism. Adipose tissue acts as a steroid hormone reservoir and may synthesize active hormones in response to different stimuli, such as inflammation, obesity or postmenopausal HT. The mechanisms linking these entities are incompletely known. In our epidemiological and clinical studies we study the risks for cardiovascular diseases and breast cancer among women using or stopping postmenopausal HT. These data will provide new information to help clinical decision-making.
Show moreStarting year
2020
End year
2024
Granted funding
Funder
Research Council of Finland
Funding instrument
Targeted Academy projects
Other information
Funding decision number
333983
Research fields
Kliiniset lääketieteet
Identified topics
public health, occupational health